tobramycin has been researched along with 2-heptyl-3-hydroxy-4-quinolone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Baig, NF; Bohn, PW; Dunham, SJB; Ellis, JF; Madukoma, CS; Morales-Soto, N; Shrout, JD; Sweedler, JV | 1 |
Abdelsamie, AS; Bals, R; Berwanger, A; Blankenfeldt, W; Börger, C; Christmann, R; Empting, M; Hamed, MM; Hartmann, RW; Herr, C; Hirsch, AKH; Ho, DK; Horstmann, JC; Kany, AM; Koch, M; Lehr, CM; Loretz, B; Murgia, X; Röhrig, T; Rox, K; Schmelz, S; Schütz, C; Scrima, A; Siebenbürger, L; Wirth, M; Yahiaoui, S | 1 |
2 other study(ies) available for tobramycin and 2-heptyl-3-hydroxy-4-quinolone
Article | Year |
---|---|
Spatially dependent alkyl quinolone signaling responses to antibiotics in
Topics: Anti-Bacterial Agents; Biofilms; Humans; Hydroxyquinolines; Mass Spectrometry; Microbial Viability; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Spectrum Analysis, Raman; Tobramycin | 2018 |
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms.
Topics: Animals; Biofilms; Disease Models, Animal; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Quorum Sensing; Tobramycin | 2021 |